drugset / Trial / NCT05467475
A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of the proton pump inhibitor esomeprazole on the pharmacokinetics of BI 1819479 in plasma.
Timeline
- Start
- 2022-10-18
- Primary completion
- 2023-01-23
- Completion
- 2023-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1819479 | Unknown | — | Oral |
| Subject | Esomeprazole | Small molecule | — | — |
Indications
No indication recorded.